It's easy to become a member of the BSI. Sign up today to connect with the largest network of immunologists in Europe and to enjoy discounts at Congress and other BSI meetings, free access to our journals, Immunology News, grants, bursaries and much more.
See more
Read the original here:
British Society for Immunology | Celebrating the first 60 years
The Department of Microbiology and Immunology provides a stimulating environment for faculty scientists and trainees who will play a leadership role in academic, government and industrial research and in international health organizations.
Advances in molecular and cell biology and genetics have opened new approaches to the basic and applied aspects of infectious diseases and host defenses. We are applying these approaches to basic aspects of receptor signaling, regulation of gene expression in both prokaryotic and eukaryotic cells and interactions between these cells, genetic manipulation of cellular functions, microbial genomics and evolution, and development of new vaccination strategies. The techniques of functional genomics, gene delivery, stem cells and transgenic/gene disruption animal models are being developed to address specific questions.
TheGraduate Program in Molecular Microbiology and Immunologyprovides interactive, multi-departmental graduate education and research training. Our graduates receive comprehensive education in molecular and cell biology, microbiology and immunology and in-depth training in their chosen area of research.
Our Ph.D. and M.D./Ph.D. students train in the laboratories of participating faculty in theInstitute for Genome Sciences,Center for Vaccine Development,Institute of Human Virology,Department of Microbial Pathogenesisin the Dental School, theUniversity of Maryland Marlene & Stewart Greenebaum Cancer Center, theProgram in the Biology of Model Systems; and the Departments ofMedicine,SurgeryandPediatrics.
More here:
Department of Microbiology and Immunology | University of ...
Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumor marker-based diagnostic tests.[1][2] For instance tumour infiltrating lymphocytes are significant in human colorectal cancer.[3] The host was given a better chance at survival if the cancer tissue showed infiltration of inflammatory cells, in particular those prompting lymphocytic reactions. The results yielded suggest some extent of anti-tumour immunity is present in colorectal cancers in humans.
Cancer immunosurveillance and immunoediting is based on (i) protection against development of spontaneous and chemically induced tumors in animal systems and (ii) identification of targets for immune recognition of human cancer.[4]
Cancer immunosurveillance is a theory formulated in 1957 by Burnet and Thomas, who proposed that lymphocytes act as sentinels in recognizing and eliminating continuously arising, nascent transformed cells.[4][5] Cancer immunosurveillance appears to be an important host protection process that decreases cancer rates through inhibition of carcinogenesis and maintaining of regular cellular homeostasis.[6] It has also been suggested that immunosurveillance primarily functions as a component of a more general process of cancer immunoediting.[4]
Immunoediting is a process by which a person is protected from cancer growth and the development of tumour immunogenicity by their immune system. It has three main phases: elimination, equilibrium and escape.[7] The elimination phase consists of the following four phases:
The first phase of elimination involves the initiation of an antitumor immune response. Cells of the innate immune system recognize the presence of a growing tumor which has undergone stromal remodeling, causing local tissue damage. This is followed by the induction of inflammatory signals which is essential for recruiting cells of the innate immune system (e.g. natural killer cells, natural killer T cells, macrophages and dendritic cells) to the tumor site. During this phase, the infiltrating lymphocytes such as the natural killer cells and natural killer T cells are stimulated to produce IFN-gamma.
In the second phase of elimination, newly synthesized IFN-gamma induces tumor death (to a limited amount) as well as promoting the production of chemokines CXCL10, CXCL9 and CXCL11. These chemokines play an important role in promoting tumor death by blocking the formation of new blood vessels. Tumor cell debris produced as a result of tumor death is then ingested by dendritic cells, followed by the migration of these dendritic cells to the draining lymph nodes. The recruitment of more immune cells also occurs and is mediated by the chemokines produced during the inflammatory process.
In the third phase, natural killer cells and macrophages transactivate one another via the reciprocal production of IFN-gamma and IL-12. This again promotes more tumor killing by these cells via apoptosis and the production of reactive oxygen and nitrogen intermediates. In the draining lymph nodes, tumor-specific dendritic cells trigger the differentiation of Th1 cells which in turn facilitates the development of cytotoxic CD8+ T cells also known as killer T-cells.
In the final phase of elimination, tumor-specific CD4+ and CD8+ T cells home to the tumor site and the cytotoxic T lymphocytes then destroy the antigen-bearing tumor cells which remain at the site.
Tumor cell variants which have survived the elimination phase enter the equilibrium phase. In this phase, lymphocytes and IFN-gamma exert a selection pressure on tumor cells which are genetically unstable and rapidly mutating. Tumor cell variants which have acquired resistance to elimination then enter the escape phase. In this phase, tumor cells continue to grow and expand in an uncontrolled manner and may eventually lead to malignancies. In the study of cancer immunoediting, knockout mice have been used for experimentation since human testing is not possible.[4]Tumor infiltration by lymphocytes is seen as a reflection of a tumor-related immune response.[8]
Obeid et al.[9] investigated how inducing immunogenic cancer cell death ought to become a priority of cancer chemotherapy. He reasoned, the immune system would be able to play a factor via a bystander effect in eradicating chemotherapy-resistant cancer cells.[10][11][12] However, extensive research is still needed on how the immune response is triggered against dying tumour cells.[13]
Professionals in the field have hypothesized that apoptotic cell death is poorly immunogenic whereas necrotic cell death is truly immunogenic.[14][15][16] This is perhaps because cancer cells being eradicated via a necrotic cell death pathway induce an immune response by triggering dendritic cells to mature, due to inflammatory response stimulation.[17][18] On the other hand, apoptosis is connected to slight alterations within the plasma membrane causing the dying cells to be attractive to phagocytic cells.[19] However, numerous animal studies have shown the superiority of vaccination with apoptotic cells, compared to necrotic cells, in eliciting anti-tumor immune responses.[20][21][22][23][24]
Thus Obeid et al.[9] propose that the way in which cancer cells die during chemotherapy is vital. Anthracyclins produce a beneficial immunogenic environment. The researchers report that when killing cancer cells with this agent uptake and presentation by antigen presenting dendritic cells is encouraged, thus allowing a T-cell response which can shrink tumours. Therefore activating tumour-killing T-cells is crucial for immunotherapy success.[25]
However, advanced cancer patients with immunosuppression have left researchers in a dilemma as to how to activate their T-cells. The way the host dendritic cells react and uptake tumour antigens to present to CD4+ and CD8+ T-cells is the key to success of the treatment.[26]
Various strains of human papillomavirus (HPV) have been found to play an important role in the development of cervical cancer. The HPV oncogenes E6 and E7 that these viruses possess have been shown to immortalise some human cells and thus promote cancer development.[27] Although these strains of HPV have not been found in all cervical cancers, they have been found to be the cause in roughly 70% of cases. The study of these viruses and their role in the development of various cancers is still continuing, however a vaccine has been developed that can prevent infection of certain HPV strains, and thus prevent those HPV strains from causing cervical cancer, and possibly other cancers as well.
A virus that has been shown to cause breast cancer in mice is mouse mammary tumor virus.[28][29] It is from discoveries such as this and the role of HPV in cervical cancer development that research is currently being undertaken to discover whether or not human mammary tumour virus is a cause of breast cancer in humans.[30][clarification needed]
Original post:
Cancer immunology - Wikipedia
Index Copernicus Value: 67.47
Immunology is a branch of biomedical science which deals with an organisms response towards an invading environmental factor. This process involves a complex interplay of invading particle and defence system of the host organism along with successive cascading molecular mechanism to eliminate the invading agent.
This peer reviewed journal includesclinical and cellular Immunologicalaspects such asSystemic Lupus Erythmatosus,Cancer Immunology, Tumor Biology,Macrophage Polarization,Transplantation Immunology, Innate Immunology, Adaptive Immunity, Cellular & Molecular Immunology, Vaccine Development,Signal Transduction, Innate Immunity, Cancer Immunotherapy,Inflammatory Disorders, Medical Immunology,Diagnostic Immunology, Clinical Immunology, HIV Immunology,Allergy & Immunology,Immunomodulation,Multiple Sclerosis, Neuroinflammatory Diseases, Clinical & Vaccine Immunology, Clinical Experimental Immunology, T-cell Immunologyetc.
This Science Journal publishes research articles, reviews, case studies, commentaries, short communications, and letters to the editor on various aspects of Cellular and Clinical Immunology making them freely available worldwide.To attain high impact factor, quality articles are expected from all over the world for this open access and peer reviewed front running journal.
Journal of Clinical & Cellular Immunology is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems used by most of the best open access journals. Review processing is performed by the editorial board members of Journal of Clinical & Cellular Immunology or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript. Annual reviews of Immunology Journal is also shared with authors.
Authors are requested to submit manuscripts at http://www.editorialmanager.com/clinicalgroup/ or send as an e-mail attachment to the Editorial Office at clinimmunology@immunologyjournals.com; cjm.eic.jcci@omicsonline.org
OMICS International organizes 1000+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Clinical immunology is the branch of Immunology that deals with studies of diseases caused due to immune system disorders. Clinical Immunology falls into two categories Immunodeficiency and Autoimmunity. Immunodeficiency is a category in which adequate response is not provided by the immune system. Whereas in Autoimmunity the immune system attacks its own host body. Related Journals of Clinical Immunology
Immunology Journals: Journal of Vaccines & Vaccination, Rheumatology: Current Research, Immunome Research, Journal of Allergy & Therapy, Journal of AIDS & Clinical Research, Allergy: European Journal of Allergy and Clinical Immunology, Autoimmunity Journal, Clinical and Experimental Immunology, Autoimmunity Reviews, Clinical Immunology, Current Opinion in Allergy and Clinical Immunology, Current Opinion in Immunology, Journal of Asthma.
Cellular immunology deals with activities of cells in experimental or clinical situations. It is the interactions among cells and molecules of the immune system that contribute to the recognition and elimination of pathogens.
Related Journals of Cellular Immunology
Open Access Immunology Journals: Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Cellular Immunology, Central-European Journal of Immunology, Chinese Journal of Microbiology and Immunology, Clinical and Developmental Immunology, Clinical and Experimental Immunology, Clinical and Vaccine Immunology.
Translational immunology is the process the use immunological discoveries to develop practical solutions for human problems. Examples include the development of vaccines or the engineering of new types of drugs to treat disorders.
Related Journals of Translational Immunology Immunology Journals List: Journal of Allergy & Therapy, Journal of AIDS & Clinical Research, Immunome Research, Journal of Allergy & Therapy, International Immunology, Current Topics in Microbiology and Immunology, Advances in Immunology, Cellular Immunology, Critical Reviews in Immunology.
Transplantation Immunology deals with monitoring Immune responses provided by the body for transplantation to prevent rejection of transplanted tissue or organ.
Related Journals of Transplantation Immunology
Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Therapy, Clinical Transplantation, Xenotransplantation, Annals of Transplantation, Cellular Therapy and Transplantation, Progress in Transplantation.
Neuroinflammatory disorder is the study of conditions where immune responses which damage components of the nervous system. It includes many neurodegenerative disorders like Alzheimers disease, Parkinsons disease and Multiple Sclerosis. It is also associated with aging and Traumatic brain injury.
Related Journals of Neuroinflammatory Disorders
Journal of Vaccines & Vaccination, Rheumatology: Current Research, Immunome Research, Journal of Allergy & Therapy, Journal of Neuroinflammation, Multiple Sclerosis, Multiple Sclerosis and Related Disorders, Alzheimer's Research and Therapy, Parkinsonism and Related Disorders.
Tumour immunology is the study of interactions between the immune system and tumour cells. It aims to discover innovative cancer immunotherapies to treat and retard progression of the disease.
Related Journals of Tumor Immunology
Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Tumor Biology, Brain Tumor Pathology, Immunology Reviews, Tumor Targeting, Journal of Tumor Marker Oncology, Nature Immunology, Tumor Diagnostik und Therapie, Cancer Case Presentations: The Tumor Board.
Vaccine Immunology deals with preparation of vaccine based on immune response of the body. Vaccine can be antigenic substance prepared from the causative agent of a disease or a synthetic substitute to provide immunity against that disease.
Related Journals of Vaccine Immunology
Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Therapy, Clinical and Vaccine Immunology, Paediatric Food Allrgy, Human Vaccines and Immunotherapeutics, Paediatric Immunology, Journal of Immune Based Therapies and Vaccines, Paediatric Allergy & Immunology, Vaccine & immunization news : the newsletter of the Global Programme for Vaccines and Immunization.
Adaptive immunity is an important part of the immune system. It is protection from an infectious disease agent that is mediated by B- and T- lymphocytes following exposure to specific antigen, and characterized by immunological memory.
Related Journals of Adaptive Immunity
Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Genes and Immunity, Brain, Behavior, and Immunity, Immunity and Ageing, Autoimmunity Highlights, Open Autoimmunity Journal.
Inflammatory abnormalities results in the body own immune system attacking the cells or tissues and may cause inflammation, which results in chronic pain, redness, swelling, stiffness, and damage to normal tissues.
Related Journals of Inflammatory Disorders
Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Immunology, Journal of Allergy & Therapy, Inflammation and Allergy - Drug Targets, Journal of Inflammation Research, Journal of Ophthalmic Inflammation and Infection, European Journal of Inflammation, Journal of Inflammation.
Ocular Immunology is the understanding of the immune response towards various allergies, inflammation and infections of ocular tissue including retina and uveitis.
Related Journals of Ocular Immunology and inflammation
Journal of Vaccines & Vaccination, Rheumatology: Current Research, Immunome Research, Journal of Allergy & Therapy, Ocular Immunology and Inflammation, Cutaneous and Ocular Toxicology, Journal of Ocular Biology, Diseases, and Informatics, Clinica Oculistica e Patologia Oculare.
It is the scientific study of infections caused by different microorganism which can lead to discovery of potent anti-microbial drug and other antibiotics.
Related Journals of Microbial Immunology
Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Applied and Environmental Microbiology, Asthma Journal, Microbiology and Molecular Biology Reviews, Trends in Microbiology, Current Opinion in Microbiology, Current Topics in Microbiology and Immunology, European Journal of Clinical Microbiology and Infectious Diseases.
Immunodiagnostics is a diagnostic method that relies on antigen-antibody reaction for detection of the disease. Immunologic methods are used as tools in the treatment and prevention of infectious diseases and immune-mediated diseases. They have high specificity and sensitivity which all depends on the value of antibody detection.
Related Journals of Diagnostic Immunology
Journal of Allergy & Therapy, Journal of AIDS & Clinical Research, Immunome Research, Journal of Allergy & Therapy, Clinical and Vaccine Immunology : CVI, Pediatric Allergy and Immunology, Supplement, Journal of Immunology Research, Comparative Immunology, Microbiology and Infectious Diseases, Clinical and Applied Immunology Reviews.
viral immunology is the study of viral infections and immune responses towards viral infections which can cause deleterious effect on the functions of the cells. It includes both DNA and RNA viral infections.
Related Journals of Viral Immunology
Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Therapy, Viral Immunology, International Immunology, Current Topics in Microbiology and Immunology, Scandinavian Journal of Immunology, Medical Microbiology and Immunology.
Immunotherapy is a form of preventive and anti-inflammatory treatment of allergy. It also deals with the study of identification of allergen and inflammatory mediators involved in allergic reaction and its treatment.
Related Journals of Allergy Immunology
Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Annals of Allergy, Asthma and Immunology, International Archives of Allergy and Immunology, Pediatric Allergy and Immunology, Current Opinion in Allergy and Clinical Immunology.
Evolutionary immunology is the study of the evolution of immunity and the immune system over ages. It includes the study and historical development of the ability to recognize foreign antigenic material.
Related Journals of Evolutionary Immunology
Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Therapy, Trends in Immunology, Transplant Immunology, European Journal of Immunology, Clinical and Experimental Immunology, Advances in Immunology.
Journal of Clinical & Cellular Immunology is supporting 4th International Conference and Exhibition on Clinical & Cellular Immunology which is going to be held during September 28-30, 2015, at Houston, USA. The theme of the conference is From Basic Immune Understanding to Clinical Breakthroughs.
Excerpt from:
Immunology Journals | Peer Reviewed | High Impact Articles list
Parasitology Conferences|Immunology Meetings|ImmunologyConferences: Conferencesseries invites all the participants from all over the world to attend'4th International Conference on Parasitology' during September 01-02, 2017 in Prague, Czech Republic which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. With members from around the world focused on learning about parasitology and its advances; this is your best opportunity to reach the largest assemblage of participants from the parasitology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Parasitology are hallmarks of this conference.
Conference Highlights:Parasitology,Medical Parasitology,Parasite Treatments,Skin Parasites,Parasitic Worms,Stool Parasites,Advances in Parasite Medications,Eye Parasites,Brain Parasites,Blood Parasites,Parasite Remedies,Fish Parasitic Diseases,Water Parasites,Veterinary Parasitology,Experimental Immunoparasitology,Structural and Molecular Parasitology,Vector-Borne Viral Diseases,Tropical Medicine Parasitology,Pathogenesis and Immunity,Malaria Research,Ticks and Tick-borne Pathogens in Tropical Veterinary Medicine,Approaches: Parasitic Disease Control.
Related Conferences:3rd World Conference on Parasitology, July 12-14, 2017, Chicago, USA, International Conference on Infection Control, September 25-26, 2017, Chicago, USA, 8thMolecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy, 9th World Conference & Expo on Immunology, November 02-03, 2017, Atlanta, USA, 8th European Immunology Conference, June 29-July 01, 2017, Madrid, Spain, 5thWorld Congress on Infectious Diseases, August 21-23, 2017 San Francisco, California, USA, 10th World Congress on Healthcare & Technologies, July 17-18, 2017 Lisbon, Portugal.
Read more here:
Immunology Conferences | Global Events | Meetings | USA ...
The Science of Immunology
The science of Immunology encompasses the study of the development, anatomy functions and malfunctions of the immune system, all of which are of fundamental importance to the understanding of human disease. The immune system is made up of many types of molecules and cells that are distributed in every tissue of the body, as well as specialized lymphoid organs, which act in a coordinated manner to prevent or eliminate microbial infections, to suppress the growth of tumors, and to initiate repair of damaged tissues. The immune system normally recognizes and responds to foreign molecules or damaged self, but not healthy host cells and tissues. The innate immune system maintains barriers to microbial invasion and provides critical biochemical and cellular first responders to infections that are absolutely essential for survival in a world teeming with microbes. Innate immune recognition initiates stereotypical inflammatory or anti-viral responses to a limited number of molecular patterns that are shared by different pathogens or expressed by injured or infected host cells. The more highly evolved adaptive immune system relies on collections of millions of clones of B and T lymphocytes to provide protection for the host, each clone capable of recognizing a distinct molecule. Furthermore, B and T lymphocytes are capable of differentiating into several different types of effector cells that perform distinct functions, and into long-lived memory cells that prevent or minimize repeat infections by a microbe.
Many diseases occur when there are fundamental defects in the immune system, or when the normal immune system is challenged in ways that evoke responses that damage rather than protect host cells and tissues. These diseases cause significant morbidity and mortality in every human population worldwide. Immunodeficiency diseases are manifest by increased risk of infections and tumors, and are caused by gene mutations, malnutrition, certain viruses such as HIV, or by treatments for cancer. Immune responses that are inappropriately targeted against self-molecules result in autoimmunity, which is manifest by diverse clinical problems related to the tissues or organs involved. Autoimmune diseases are caused by a combination of inherited genes and environmental factors that result in a failure of the mechanisms of self-tolerance and immune regulation. Excessive or chronic immune responses to infections are often the cause of disease related to certain microbes that are not cytopathic by themselves. Similarly, immune responses to otherwise nonpathogenic environmental antigens are the basis for allergic diseases. As the science of Immunology has progressed, it has become clear that immune responses are key to the development of many common disorders not traditionally viewed as immunologic in nature, including metabolic, cardiovascular, neurodegenerative, and neoplastic diseases.
Harvard investigators have historically made many major contributions to the field of Immunology (see History of Immunology at Harvard). Current research activities at Harvard Medical School and affiliated institutions promise to bring more important discoveries and development of new therapies. Some examples of these activities include:
Browse People and Labs to find out more about the current scope of Harvard Immunology research.
Read more:
What is immunology? | Harvard Immunology
Departmental Focus
Immunology is the study of the immune system, the body's defense against infectious disease. In this complex system a defect in a single gene or the control of a single cell can have an enormous effect on the health of the individual. In this way, the immune system and cancer are similar. The Department of Immunology at St. Jude studies the biology of the system whose cells are a major source of childhood cancers, and by understanding these cells and how they are controlled, we gain new insights into such cancers.
Department of Immunology MS 351, Room E7050 St. Jude Children's Research Hospital 262 Danny Thomas Place Memphis, TN 38105-3678
Email: douglas.green@stjude.org Phone: (901) 595-3488 Fax: (901) 595-5766
Preferred contact method: email
See the article here:
Immunology - St. Jude Childrens Research Hospital
The Immunology Service at CHOP provides sensitive, patient-centered care to children and young adults with immune deficiencies. Our team team works closely with your whole family to provide education about immune deficiencies, as well as comprehensive immunology therapies.
We also help connect you with other families facing similar medical challenges, so you can learn from others who understand your experiences.
Primary immune deficiency disease can present in many ways including recurrent infections, unusual infections and autoimmune diseases. Our expert staff is world renowned in the diagnosis of these diseases. Our Clinical Immunology Laboratory provides advanced diagnostic tools, which are critical to finding an accurate diagnosis for your child and beginning a treatment plan that will improve her quality of life.
Particular areas of clinical emphasis include:
Each of the nearly 150 primary immune deficiency diseases has a specific therapy. We offer the most up-to-date therapies for our patients.
Many patients can be treated with probiotics, medications and other interventions to improve their quality of life. Hospital admissions are infrequent and the emphasis is on a normal life style. We work with our Day Medicine Unit for infusion therapy and use home care to maximize time spent at home.
Our Transition Clinic supports young adults as they become more independent and their medical needs change. We emphasize management of immune deficiencies as a way of life rather than an illness that restricts opportunities.
The Immunology Service participates in longitudinal registries of patients with immune deficiencies that aim to define optimal treatments of these diseases. These studies include USIDNET, CIBMTR and PIDTC. Ongoing research efforts are focused on:
Visit link:
Immunology Service | Children's Hospital of Philadelphia
Conference Series LLClook forward to welcoming all the participants across the globe to attend19thEuro Global Summit and Expo on Vaccines & Vaccinationgoing to be held duringJune 19-21, 2016 in Paris, France. The conference highlights the theme Accelerating Next Generation Vaccines for Global Health covering all important aspects in Vaccines and therapeutics.
Euro Vaccines 2017conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions.
Track 1:Human Vaccines - Infectious & Non Infectious Diseases
Avaccineis an inactivated form of bacteria or virus that is injected into the body to simulate an actualinfection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate animmune responseby the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate theimmune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA
Track 2:Vaccine Research & Development:
Vaccine Developmentis an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedentedEbola diseaseoutbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA
Track 3:Cancer Vaccines:
Immunotherapeuticsis treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat. The main types of immunotherapy now being used to treat cancer include:
Some types ofimmunotherapyare also sometimes called biologic therapy or biotherapy.
In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and theyll impact how we treat cancer in the future.
Immunotherapy includes treatments that work in different ways. Some boost the bodys immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. Its used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro GlobalSummit on Cancer Therapy, Sept 26-28, 2016, UK; InternationalConference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World;Vaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA
Track 4:HIV Vaccines:
AnAIDSvaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A preventive vaccine would stopHIV infectionoccurring altogether, whereas a therapeutic vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind allHIV vaccinesis to encourage the humanimmune systemto fight HIV.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; AnnualConference on Virulent HIV Vaccines, July 28-30, 2016 Thailand; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; HIV Research for Prevention 2016, 17-21 October, Chicago, USA; InternationalAIDS Conference2016, July 17-19, 2016, Durban, South Africa;HIV Trials Network Meeting, MAY 18-20, 2016, Washington D.C., USA;HIV Vaccines(X8), March 2024, 2016, California, USA;HIV Research for Prevention2016 (HIVR4P), October 17- 20, 2016, Chicago, USA
Track 5:Vaccines safety& Efficacy:
Vaccines are the best defense we have against serious, preventable, and sometimes deadlycontagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may behealth risk. Accurate information about the value of vaccines as well as their possibleside-effectshelps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used. Find out about what is done before and after vaccines are approved for use and what is known about the benefits and safety of specific vaccines. There is a lot of false information about vaccines safety on the Internet. This can be confusing. Discover the answers to common questions and concerns about vaccines.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA
Track 6:Vaccination for Pregnant Women:
Vaccines can help keep you and your growing family healthy. If you are pregnant or planning apregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. All women who will be pregnant (any trimester) during the flu season should be offered this vaccine. Talk to your doctor to see if this applies to you.Tetanus/Diphtheria/Pertussis(Tdap): Tdap is recommended during pregnancy, preferably between 27 and 36 weeks' gestation, to protect baby from whooping cough.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France;Pregnancy Summit& Child Health, Aug 29-31, 2016, Brazil; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA
Track 7:Childhood Vaccines:
Vaccinationgiven to children is called childrenImmunization. It is currently recommended that all children receive vaccination against the infectious diseases unless the child has special circumstances, such as a compromised immune system orneurological disorders. In our mobile society, over a million people each day people travel to and from other countries, where many vaccine-preventable diseases remain relatively common. Without vaccines, epidemics of many preventable diseases could return, resulting in increased - and unnecessary - illness, disability, and death among children.
We have record or near record low levels of vaccine-preventable childhood diseases in the United States, but that does not mean these have disappeared. Many of the viruses and bacteria are still circulating in this country or are only a plane ride away. Thats why its important that children, especially infants and young children receive recommended immunizations on time.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA
Track 8:Vaccine Adjuvants & Delivery Technologies:
Vaccine adjuvants - is an ingredient of a vaccine that helps create a stronger immune response in the patients body. In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protectiveimmune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccines ingredients that have been used in vaccines since the 1930s. Small amounts of aluminum are added to help the body build strongerimmunityagainst the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).
Drug deliverysystems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug deliverysuch as transport in the circulatory system and drug movement through cells and tissuesthey have contributed to the development of a number of new modes of drug delivery that have entered clinical practice. Role of vaccine delivery technologies includes rational development of vaccines, achievingimmunizationgoals, supporting best clinical practice.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; 8th InternationalConference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 7-9, 2016, Spain; 9th WorldDrug Delivery Summit, June 30-July 2, 2016, USA; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE;Drug Delivery CongressEurope, Germany; 13th Annual InternationalNanomedicine and Drug Delivery Symposium, USA;Vaccines for Children & Vaccine Preventable Disease ConferenceSouth Iselin, NJ; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA
Track 9:Immunization for Older Adults:
Vaccines are an important part of routine preventive care for older adults, but most adults dont get their vaccines as recommended. Omittingvaccinationleaves adults needlessly vulnerable to severe illnesses, long-term suffering and death from preventable infections. Vaccines are recommended for adults of all ages, they are particularly important for older persons who are at great risk of serious debilitating consequences and death frominfectious diseases. Vaccination is particularly important for individuals living in nursing homes or assisted living facilities, as disease can spread easily among people in close proximity.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France;Geriatric Medicine Conference, Nov 17-19, 2016, USA; 3rd InternationalConference on Geriatrics & Gerontology, Aug 15-17, 2016, UK; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA
Track 10:Vaccines against Viral and Bacterial Diseases:
Most vaccines againstviral infectionare effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.
It is difficult for many of us today to appreciate the dangers of childhood viral infections.
Most of the vaccines in use againstvirusesare very effective at preventingdisease. However, for a variety of reasons, they can fail:
The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.
Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.
Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available againsttuberculosis,diphtheria,tetanus,pertussis, Haemophilus influenzae type B,cholera, typhoid, and Streptococcus pneumoniae.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia;Vaccine Summit, UK; BIT's 6th AnnualWorld Congress of Vaccine, China; 9thVaccines & ISV Congress, South Korea; WorldVaccines Congress, USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 2ndAntivirals CongressMassachusetts, United States;Vaccinology conferenceSydney Australia;Vaccines R&D conference-2015 A New Era in Vaccine Discovery Baltimore, USA; MoldovaVaccine Summit, UK;Immunotherapy and Vaccine SummitBoston, USA
Track 11:DNA Vaccines:
DNA vaccinationis a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.
Vaccinationconsists of stimulating the immune system with an infectious agent, or components of an infectious agent, modified in such a manner that no harm or disease is caused, but ensuring that when the host is confronted with that infectious agent, the immune system can adequately neutralize it before it causes any ill effect. For over a hundred years vaccination has been effected by one of two approaches: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime theimmune system.
The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing theimmune response. Ultimately, the distinction between a sophisticated DNA vaccine and a simple viral vector may not be clear. Many aspects of the immune response generated by DNA vaccines are not understood. However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA
Track 12:HPV Vaccines:
Human Papillomavirus (HPV)vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.
These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.
RoutineHPV Vaccination
It is important for girls to get HPV vaccine before their first sexual contact -- because they have not been exposed to HPV. For these girls, the vaccine can prevent almost 100% of disease caused by the four types of HPV targeted by the vaccine. However, if a girl or woman is already infected with a type of HPV, the vaccine will not prevent disease from that type. The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Human Papillomavirus, May 2-3, 2016, USA; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA
Track 13:Tuberculosis Vaccines:
BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculousmeningitisand miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection withMycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccines potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; The 2016TB Summit: 21 23 June 2016, London, UK;EMBO conference Tuberculosis2016, September 19-23, 2016, Paris, France; 20th AnnualTB Conference, February 24-27, 2016, Colorado, USA; ICTT 2016 : 18th InternationalConference on Tuberculosis Therapy, February 25 - 26, 2016, London, United Kingdom; 47th Union WorldConference on Lung Health, 25-29 October 2016, Liverpool, UK; Joint 20thConference of The Union North America Region and the National TB Controllers Association, 24-27 February 2016, Colorado, USA
Track 14:Mucosal vaccines:
Mostinfectious agentsenter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosalimmune system(dispersed or organised into units such as Peyers patches in the intestine or the nasal-associated lymphoidtissuein the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA
Track 15:Vaccines for Vector-borne Diseases:
Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens.Vector-borne diseasesare among the most complex of all infectious diseases to prevent and control. Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines.
Historically, successful vector-borne disease prevention resulted from management or elimination of vector populations.Malariawas driven out of the USA and most of Europe in this way. Where vector control has been consistently applied in the past, the results have been dramatic, especially with early efforts to control malaria by spraying the inside surfaces of houses with insecticides. Indoor Residual Spraying (IRS) and long-lasting insecticide treated bednets have been very effective over the last 10 years and are widely regarded as one of the main contributors to the more than 1 million lives saved.
In contrast to expenditure and effort on medicine, diagnostic andvaccine development, relatively little attention was given to vector control in the past. The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro GlobalSummit on Cancer Therapy, Sept 26-28, 2016, UK; InternationalConference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA
Track 16:Human Preventive& Therapeutic Vaccines:
Apreventative vaccineis administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases likepolio,chicken pox,measles, mumps, rubella,influenza(flu), and hepatitis A and B.
In addition to preventive vaccines, there are also therapeutic vaccines. These are vaccines that are designed to treat people who already have a disease. Some scientists prefer to refer to therapeutic vaccines as therapeutic immunogens.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA
Track 17:Plant-based vaccines:
Plant-basedvaccinesare recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oraldrug deliveryin the form of an edible vaccine. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, andanimal vaccineprojects have given promising data in early phase trials targeting specific animal species.
The plant-based vaccine production method works by isolating a specific antigen protein, one that triggers a humanimmune responsefrom the targeted virus. A gene from the protein is transferred to bacteria, which are then used to infect plant cells. The plants then start producing the exact protein that will be used for vaccinations. The flexibility of the plant expressed vaccine system, combined with its low cost and ability to massively scale may provide vaccine protection not only to citizens of the United States, but to many parts of the world that cannot currently afford vaccines. Other uses of plant expressed vaccines including the successful creation of edible bananas that protect against the Norwalk virus.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA
Track 18: Veterinary vaccines:
Veterinary vaccinesare to improve the health and welfare of companion animals, increase production of livestockin a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Several vaccine types can de distinguished among the second-generation veterinary vaccines, depending whether they are live or inactivated, according to the strain of rabies virus used and the characteristics of the cell substrate chosen for viral replication. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parenterally or orally.Oral rabies vaccinesare widely used in foxes in Europe and in racoons in the USA.
Vaccines Conferences|Immunology Conferences|World Vaccines Congress
Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA
Read the original post:
Vaccines Conferences | Immunology Conferences | World ...
Vols. 147 to 149; 2016 Vols. 144 to 146; 2015 Vols. 141 to 143; 2014 Vols. 138 to 140; 2013 Vols. 135 to 137; 2012 Vols. 132 to 135; 2011 Vols. 129 to 131; 2010 Vols. 126 to 128; 2009 Vols. 123 to 125; 2008 Vols. 120 to 122; 2007 Vols. 117 to 119; 2006 Vols. 114 to 116; 2005 Vols. 111 to 113; 2004 Vols. 108 to 110; 2003 Vols. 105 to 107; 2002 Vols. 102 to 104; 2001 Vols. 99 to 101; 2000 Vols. 96 to 98; 1999 Vols. 93 to 95; 1998 Vols. 90 to 92; 1997 Vols. 87 to 89; 1996 Vols. 84 to 86; 1995 Vols. 81 to 83; 1994 Vols. 78 to 80; 1993 Vols. 75 to 77; 1992 Vols. 72 to 74; 1991 Vols. 69 to 71; 1990 Vols. 66 to 68; 1989 Vols. 63 to 65; 1988 Vols. 60 to 62; 1987 Vols. 57 to 59; 1986 Vols. 54 to 56; 1985 Vols. 51 to 53; 1984 Vols. 48 to 50; 1983 Vols. 45 to 47; 1982 Vols. 42 to 44; 1981 Vols. 39 to 41; 1980 Vols. 36 to 38; 1979 Vols. 34 to 35; 1978 Vols. 32 to 33; 1977 Vols. 30 to 31; 1976 Vols. 28 to 29; 1975 Vols. 26 to 27; 1974 Vols. 24 to 25; 1973 Vols. 22 to 23; 1972 Vols. 20 to 21; 1971 Vols. 18 to 19; 1970 Vols. 16 to 17; 1969 Vols. 14 to 15; 1968 Vols. 12 to 13; 1967 Vols. 10 to 11; 1966 Vols. 8 to 9; 1965 Vol. 7 1964 Vol. 6 1963 Vol. 5 1962 Vol. 4 1961 Vol. 3 1960 Vol. 2 1959 Vol. 1 1958
See more here:
Archive of "Immunology".